Skip to content

Clinical trials

Phase 3 Eye Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 3 Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20131
20162
20182
20191
20202
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GenSight Biologics4
Kodiak Sciences Inc2
AbbVie1
Bayer1
Centre Hospitalier Intercommunal Creteil1
Laboratoires Thea1
Novartis Pharmaceuticals1
Opthea Limited1
Vanda Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases13
Retinal Diseases8
Retinal Degeneration6
Vision Disorders6
Eye Diseases, Hereditary5
Macular Degeneration5
Optic Atrophy, Hereditary, Leber5
Blindness4
Mitochondrial Diseases4
Nervous System Diseases4

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.